Regular Aspirin Use Reduces Risk for Colorectal Cancer Precursors

February 13, 2009 — The results of observational studies and randomized trials suggest that regular use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the risk of developing colorectal adenomas, which are known precursors to colorectal cancer.

The results of 2 new studies, published in the February 18 issue of the Journal of the National Cancer Institute, add strength to the evidence that aspirin may be an effective means of chemoprevention in high-risk individuals.